Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 15, 2023

Study Completion Date

December 15, 2023

Conditions
Interstitial CystitisBladder Pain Syndrome
Interventions
DIAGNOSTIC_TEST

Polymerase Chain Reaction and Next-Generation DNA Sequencing

"The qPCR Rapid Screening Panel is a quantitative real-time PCR test for bacteria and fungi.~Next-Generation DNA Sequencing is the Comprehensive Sequencing test will detect virtually all microbial organisms and fungal pathogens that may be present in patient specimens."

Trial Locations (4)

27103

COMPLETED

Wake Forest University Baptist Medical Center Urology, Winston-Salem

90095

RECRUITING

UCLA Center for Women's Pelvic Health, Los Angeles

92103

RECRUITING

The University of California San Diego Health, San Diego

08103

RECRUITING

Cooper University Health Care, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MicroGenDX

INDUSTRY

NCT05276466 - Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms | Biotech Hunter | Biotech Hunter